Tesla, THC and the Transfer That Never Happened: Why a California Lawsuit Could Matter Beyond One Employee

Burn After Reading The 30-second intel for operators and investors ⏱ 0:30

Tesla faces a California lawsuit from employee Mark Dollard, who alleges it blocked a job transfer over a positive THC test despite his medical cannabis registration and off-duty use. The outcome may hinge on whether the test predates California's January 1, 2024 protections.

• Operators: Operators who argue impairment, not metabolites, should drive workplace policy see that debate reaching mainstream employers. Your own HR policies face the same question of separating past use from impairment, plus accommodation duties.
• Investors: The case is unproven and Tesla has not publicly responded. It shows employment-law risk growing as states bar discrimination over lawful off-duty cannabis use, which may shape employer drug-testing norms across industries.
• Do now: Review your drug-testing and accommodation policies against California's off-duty cannabis rules and their exceptions, and check that documented accommodation steps exist before any adverse employment decision.

Short on time? You’re done. Want the numbers?Keep reading ↓

For years, cannabis advocates joked that Silicon Valley ran on caffeine by day and cannabis by night. Now, one of its biggest companies is being asked to explain where it draws the line.

Tesla is facing a lawsuit in California from employee Mark Dollard, who alleges the company discriminated against him because of his off-duty medical cannabis use and later retaliated after he complained to state regulators. The case has all the ingredients of a modern employment dispute: disability accommodation, workplace drug testing, evolving cannabis laws—and, because it’s Tesla, a level of public attention few employers ever attract.

No, this lawsuit isn’t about someone showing up to assemble Model Ys while high. That’s an important distinction.

A Job Transfer That Hit a Roadblock

According to the complaint, Dollard joined Tesla’s Fremont, California, manufacturing facility in May 2022. He says the company knew he had a chronic knee condition when he was hired.

After knee surgery in late 2023 left him unable to continue performing his original role, Tesla allegedly encouraged him to apply for another position within the company. That transfer required a drug screening, which reportedly returned positive for THC.

Dollard argues Tesla rejected the transfer solely because of that result, despite his status as a registered medical cannabis patient and despite the cannabis use occurring outside working hours.

The lawsuit also alleges Tesla failed to meaningfully explore whether a reasonable accommodation was possible before denying the transfer.

If proven, that issue—not cannabis itself—could become one of the case’s central legal questions.

Then Came the Retaliation Claim

The complaint goes further.

After filing a discrimination complaint with California regulators earlier this year, Dollard alleges managers began closely monitoring his workplace activities in search of reasons to discipline him.

He also claims he was warned about attendance issues despite still having accrued paid leave following medical absences.

Those allegations remain unproven, and Tesla has not publicly responded to the claims in court.

California Changed the Rules

Timing may ultimately determine whether this case becomes a landmark—or simply another employment dispute.

Beginning January 1, 2024, California generally prohibited employers from discriminating against workers for lawful cannabis use during non-working hours. The law reflects a growing recognition that traditional THC tests often detect past consumption rather than current impairment.

In other words, testing positive for THC does not necessarily mean someone is impaired at work—much like finding coffee grounds doesn’t prove someone is currently drinking espresso.

There are important exceptions. Construction jobs, positions regulated by federal law, and certain safety-sensitive roles can still be subject to different requirements.

One unresolved question is when Dollard actually took the drug test. Court filings reportedly place it “in or around 2023 and 2024.” If the screening occurred before California’s new employment protections took effect, Tesla could argue the statute does not apply.

That timeline may become one of the lawsuit’s most important facts.

Why Cannabis Businesses Should Care

At first glance, this looks like another lawsuit involving a company that rarely stays out of headlines. (At this point, following Tesla litigation almost feels like keeping up with the Marvel Cinematic Universe—there’s always another installment.)

But the implications extend well beyond Tesla.

As more states prohibit discrimination based on lawful off-duty cannabis use, employers across industries face a new challenge: separating evidence of past consumption from evidence of workplace impairment.

That distinction matters because THC can remain detectable long after any intoxicating effects have disappeared.

For cannabis operators, who have spent years arguing that impairment—not metabolites—should determine workplace policy, the lawsuit reflects a debate that is increasingly moving into mainstream corporate America.

The Bottom Line

Whether Tesla ultimately wins or loses may depend less on cannabis than on chronology.

If the drug test occurred before California’s employment protections became effective, the legal analysis could look very different than if it occurred afterward.

Either way, the case underscores a broader reality: as more states modernize employment laws around cannabis, HR departments may need to update their policies just as quickly as software updates roll out to electric vehicles.

And unlike a Tesla, those updates can’t simply be downloaded overnight.